A geometric deep-learning model is faster and more accurate than state-of-the-art computational models, reducing the chances and costs of drug trial failures.
Rapid increases in the speed and power of microchips have fueled innovation in many industries, but the future trajectory of that incredible progress may be in jeopardy.
